Measurement of Specific Heat and Crystallization in VS55, DP6, and M22 Cryoprotectant Systems with and Without Sucrose

Shaunak Phatak, Harishankar Natesan, Jeunghwan Choi, Kelvin G.M. Brockbank, John C Bischof

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Cryopreservation represents one if not the only long-term option for tissue and perhaps future organ banking. In one particular approach, cryopreservation is achieved by completely avoiding ice formation (or crystallization) through a process called vitrification. This "ice-free" approach to tissue banking requires a combination of high-concentration cryoprotective additives such as M22 (9.4 M), VS55 (8.4 M), or DP6 (6 M) and sufficiently fast rates of cooling and warming to avoid crystallization. In this article, we report the temperature-dependent specific heat capacity of the above-mentioned cryoprotective additives in small volumes (10 mg sample pans) at rates of 5°C/min and 10°C/min using a commercially available differential scanning calorimetry (TA Instruments Q1000), in the temperature range of-150°C to 30°C. This data can be utilized in heat-transfer models to predict thermal histories in a cryopreservation protocol. More specifically, the effects of temperature dependence of specific heat due to the presence of three different phases (liquid, ice, and vitreous phase) can dramatically impact the thermal history and therefore the outcome of the cryopreservation procedure. The crystallization potential of these cryoprotectants was also investigated by studying cases of maximal and minimal crystallization in VS55 and DP6, where M22 did not crystallize under any rates tested. To further reduce crystallization in VS55 and DP6, a stabilizing sugar (sucrose) was added in varying concentrations (0.15 M and 0.6 M) and was shown to further reduce crystallization, particularly in VS55, at modest rates of cooling (1°C/min, 5°C/min, and 10°C/min).

Original languageEnglish (US)
Pages (from-to)270-277
Number of pages8
JournalBiopreservation and Biobanking
Volume16
Issue number4
DOIs
StatePublished - Aug 1 2018

Fingerprint

Crystallization
Specific heat
Sucrose
Hot Temperature
Cryopreservation
Ice
Temperature
Tissue Banks
Tissue
Cooling
Vitrification
Differential Scanning Calorimetry
Sugars
Differential scanning calorimetry
Heat transfer
Liquids

Keywords

  • Cryoprotective agents
  • DP6
  • VS55
  • specific heat
  • sucrose
  • vitrification

PubMed: MeSH publication types

  • Journal Article

Cite this

Measurement of Specific Heat and Crystallization in VS55, DP6, and M22 Cryoprotectant Systems with and Without Sucrose. / Phatak, Shaunak; Natesan, Harishankar; Choi, Jeunghwan; Brockbank, Kelvin G.M.; Bischof, John C.

In: Biopreservation and Biobanking, Vol. 16, No. 4, 01.08.2018, p. 270-277.

Research output: Contribution to journalArticle

Phatak, Shaunak ; Natesan, Harishankar ; Choi, Jeunghwan ; Brockbank, Kelvin G.M. ; Bischof, John C. / Measurement of Specific Heat and Crystallization in VS55, DP6, and M22 Cryoprotectant Systems with and Without Sucrose. In: Biopreservation and Biobanking. 2018 ; Vol. 16, No. 4. pp. 270-277.
@article{2cc70111c0b54ae8ad1ccd8d87b2bc0b,
title = "Measurement of Specific Heat and Crystallization in VS55, DP6, and M22 Cryoprotectant Systems with and Without Sucrose",
abstract = "Cryopreservation represents one if not the only long-term option for tissue and perhaps future organ banking. In one particular approach, cryopreservation is achieved by completely avoiding ice formation (or crystallization) through a process called vitrification. This {"}ice-free{"} approach to tissue banking requires a combination of high-concentration cryoprotective additives such as M22 (9.4 M), VS55 (8.4 M), or DP6 (6 M) and sufficiently fast rates of cooling and warming to avoid crystallization. In this article, we report the temperature-dependent specific heat capacity of the above-mentioned cryoprotective additives in small volumes (10 mg sample pans) at rates of 5°C/min and 10°C/min using a commercially available differential scanning calorimetry (TA Instruments Q1000), in the temperature range of-150°C to 30°C. This data can be utilized in heat-transfer models to predict thermal histories in a cryopreservation protocol. More specifically, the effects of temperature dependence of specific heat due to the presence of three different phases (liquid, ice, and vitreous phase) can dramatically impact the thermal history and therefore the outcome of the cryopreservation procedure. The crystallization potential of these cryoprotectants was also investigated by studying cases of maximal and minimal crystallization in VS55 and DP6, where M22 did not crystallize under any rates tested. To further reduce crystallization in VS55 and DP6, a stabilizing sugar (sucrose) was added in varying concentrations (0.15 M and 0.6 M) and was shown to further reduce crystallization, particularly in VS55, at modest rates of cooling (1°C/min, 5°C/min, and 10°C/min).",
keywords = "Cryoprotective agents, DP6, VS55, specific heat, sucrose, vitrification",
author = "Shaunak Phatak and Harishankar Natesan and Jeunghwan Choi and Brockbank, {Kelvin G.M.} and Bischof, {John C}",
year = "2018",
month = "8",
day = "1",
doi = "10.1089/bio.2018.0006",
language = "English (US)",
volume = "16",
pages = "270--277",
journal = "Biopreservation and Biobanking",
issn = "1947-5535",
publisher = "Mary Ann Liebert Inc.",
number = "4",

}

TY - JOUR

T1 - Measurement of Specific Heat and Crystallization in VS55, DP6, and M22 Cryoprotectant Systems with and Without Sucrose

AU - Phatak, Shaunak

AU - Natesan, Harishankar

AU - Choi, Jeunghwan

AU - Brockbank, Kelvin G.M.

AU - Bischof, John C

PY - 2018/8/1

Y1 - 2018/8/1

N2 - Cryopreservation represents one if not the only long-term option for tissue and perhaps future organ banking. In one particular approach, cryopreservation is achieved by completely avoiding ice formation (or crystallization) through a process called vitrification. This "ice-free" approach to tissue banking requires a combination of high-concentration cryoprotective additives such as M22 (9.4 M), VS55 (8.4 M), or DP6 (6 M) and sufficiently fast rates of cooling and warming to avoid crystallization. In this article, we report the temperature-dependent specific heat capacity of the above-mentioned cryoprotective additives in small volumes (10 mg sample pans) at rates of 5°C/min and 10°C/min using a commercially available differential scanning calorimetry (TA Instruments Q1000), in the temperature range of-150°C to 30°C. This data can be utilized in heat-transfer models to predict thermal histories in a cryopreservation protocol. More specifically, the effects of temperature dependence of specific heat due to the presence of three different phases (liquid, ice, and vitreous phase) can dramatically impact the thermal history and therefore the outcome of the cryopreservation procedure. The crystallization potential of these cryoprotectants was also investigated by studying cases of maximal and minimal crystallization in VS55 and DP6, where M22 did not crystallize under any rates tested. To further reduce crystallization in VS55 and DP6, a stabilizing sugar (sucrose) was added in varying concentrations (0.15 M and 0.6 M) and was shown to further reduce crystallization, particularly in VS55, at modest rates of cooling (1°C/min, 5°C/min, and 10°C/min).

AB - Cryopreservation represents one if not the only long-term option for tissue and perhaps future organ banking. In one particular approach, cryopreservation is achieved by completely avoiding ice formation (or crystallization) through a process called vitrification. This "ice-free" approach to tissue banking requires a combination of high-concentration cryoprotective additives such as M22 (9.4 M), VS55 (8.4 M), or DP6 (6 M) and sufficiently fast rates of cooling and warming to avoid crystallization. In this article, we report the temperature-dependent specific heat capacity of the above-mentioned cryoprotective additives in small volumes (10 mg sample pans) at rates of 5°C/min and 10°C/min using a commercially available differential scanning calorimetry (TA Instruments Q1000), in the temperature range of-150°C to 30°C. This data can be utilized in heat-transfer models to predict thermal histories in a cryopreservation protocol. More specifically, the effects of temperature dependence of specific heat due to the presence of three different phases (liquid, ice, and vitreous phase) can dramatically impact the thermal history and therefore the outcome of the cryopreservation procedure. The crystallization potential of these cryoprotectants was also investigated by studying cases of maximal and minimal crystallization in VS55 and DP6, where M22 did not crystallize under any rates tested. To further reduce crystallization in VS55 and DP6, a stabilizing sugar (sucrose) was added in varying concentrations (0.15 M and 0.6 M) and was shown to further reduce crystallization, particularly in VS55, at modest rates of cooling (1°C/min, 5°C/min, and 10°C/min).

KW - Cryoprotective agents

KW - DP6

KW - VS55

KW - specific heat

KW - sucrose

KW - vitrification

UR - http://www.scopus.com/inward/record.url?scp=85051321238&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85051321238&partnerID=8YFLogxK

U2 - 10.1089/bio.2018.0006

DO - 10.1089/bio.2018.0006

M3 - Article

C2 - 29958001

AN - SCOPUS:85051321238

VL - 16

SP - 270

EP - 277

JO - Biopreservation and Biobanking

JF - Biopreservation and Biobanking

SN - 1947-5535

IS - 4

ER -